Tondell et al. demonstrated that CD200 expression was higher in intratumoral CD4+ T cells from patients with NSCLC than that in CD4+ T cells from normal lungs, and further elucidated the relationship between elevated CD200 expression in lung cancer tissue and reduced survival [112]. The gene discussed is CD4; the disease is lung carcinoma.